Ilumya® (tildrakizumab) is a prescription medicine that is FDA-approved to treat adults with moderate to severe plaque psoriasis. Ilumya® is given by injection under the skin at weeks 0 and 4, then after every 12 weeks.

In clinical trials, 6 out of 10 patients taking Ilumya were clear or almost clear in as soon as 3 months.

If your psoriasis is not improving with other treatment options, and you think you would benefit from Ilumya® (tildrakizumab), talk to your Tono dermatologist about this medication.

You might also find helpful